Paratek Pharmaceuticals Inc (PRTK) stock is higher by 3.75% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With PRTK Stock Today?
Paratek Pharmaceuticals Inc (PRTK) stock is trading at $6.91 as of 1:34 PM on Wednesday, Feb 3, a gain of $0.17, or 2.52% from the previous closing price of $6.74. The stock has traded between $6.67 and $6.99 so far today. Volume today is above average. So far 499,527 shares have traded compared to average volume of 390,180 shares.
To see the top 5 stocks in the Biotechnology industry click here.
More About Paratek Pharmaceuticals Inc
Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology to create two antibacterials: omadacycline and sarecycline. Omadacycline is an antibacterial for skin infections and treatment of community-acquired bacterial pneumonia. Sarecycline is designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals is also involved in research to treat multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.
Click Here to get the full Stock Score Report on Paratek Pharmaceuticals Inc (PRTK) Stock.
